Therapeutic Cancer Vaccines
Therapeutic Cancer Vaccines and Antiangiogenic Treatments Combinations
Therapeutic Cancer Vaccines and Immune Checkpoint Blockade Combinations
Therapeutic vaccines are that vaccines which are directed after an infection or a disease have already occurred. The therapeutic vaccines works by activating the immunity power of a patient to fight against an infectious disease. There is difference between a therapeutic vaccine and a prophylactic vaccine as the prophylactic vaccines are administered to living organisms as a precautionary measure to prevent the infection or disease while the therapeutic vaccines are administered to individual after the individual is already affected by the disease or infection.
Title : Vaccines and monoclonal antibodies in the prolonged treatment of non-small cell lung cancer: 20 years of follow-up
Mayra Ramos Suzarte, Center of Molecular Immunology, Cuba
Title : Observational study post emergency use authorization of itolizumab in the treatment of COVID-19
Mayra Ramos Suzarte, Center of Molecular Immunology, Cuba
Title : Vaccine for AML: 2023 and beyond
Stefan Gluck, Jessica McDonough PhD Co-Founder Attivare, United States
Title : Purification process development of COVID antigens to identify sera needed for plasma therapy
Sushmita Koley, Senior Scientist Bio-Rad Laboratories, United States
Title : Lessons that can be learned from the rollout of the COVID-19 vaccine and the acceptance of vaccination from healthcare professionals, frontline workers and patients that need to be considered in developing a vaccine
Regina Au, BioMarketing insight, United States
Title : Lessons learned for the future of social listening to address vaccine misinformation
Joseph Smyser, The Public Good Projects, United States
Title : Why Low-Energy-Electron Irradiation might be a potential game changer for vaccine development, manufacturing, and pandemics prevention
Daniel Becker, KyooBe Tech GmbH, Germany
Title : National immunization management system- NIMS
Kashif Zulfiqar, Project Manager - NADRA, Pakistan
Title : Medicinal synthetic aluminum-magnesium silicate {Al4 (SiO4)3 + 3Mg2SiO4?2Al2 Mg3 (SiO4)3} effective for: Viral diseases; Tumors; Antimicrobial resistant infections
Maduike Chiehiura Onwubiko Ezeibe, Michael Okpara University of Agriculture, Nigeria
Title : Moving the needle for covid-19 vaccinations in Nigeria through leadership, accountability, and transparency
Fejiro Chinye Nwoko, Nigeria Solidarity Support Fund, Nigeria